ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 81 filers reported holding ONCTERNAL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,000 | +73.9% | 10,000 | +100.0% | 0.00% | – |
| Q2 2023 | $1,725 | -56.1% | 5,000 | 0.0% | 0.00% | – |
| Q1 2023 | $3,925 | -21.5% | 5,000 | 0.0% | 0.00% | – |
| Q4 2022 | $5,000 | +25.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -33.3% | 5,000 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $6,000 | -14.3% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | -36.4% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $11,000 | -47.6% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $21,000 | -12.5% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | -42.9% | 5,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $42,000 | +75.0% | 5,000 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $24,000 | +242.9% | 5,000 | +25.0% | 0.00% | +100.0% |
| Q3 2020 | $7,000 | -36.4% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | -8.3% | 4,000 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $12,000 | -36.8% | 4,000 | -18.4% | 0.00% | 0.0% |
| Q4 2019 | $19,000 | -20.8% | 4,900 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $24,000 | – | 4,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,256,717 | $3,569,000 | 0.16% |
| DOWLING & YAHNKE LLC | 150,464 | $427,000 | 0.04% |
| Aureus Asset Management, LLC | 70,211 | $199,000 | 0.02% |
| IEQ CAPITAL, LLC | 72,217 | $205,000 | 0.01% |
| Cohen Capital Management, Inc. | 13,046 | $37,000 | 0.01% |
| Creative Planning | 487,737 | $1,385,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 84,605 | $240,000 | 0.00% |
| North Star Investment Management Corp. | 4,000 | $11,000 | 0.00% |
| DELTA ASSET MANAGEMENT LLC/TN | 7 | $0 | 0.00% |
| MORGAN STANLEY | 21,342 | $61,000 | 0.00% |